← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Emocha Mobile Health, Inc.
Owings Mills, MD
$11,616,632
Total funding
8
Grants
Funding over time
peak $2.5M · FY2015–25$5M$3.8M$2.5M$1.3M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,616,632 · 8
By mechanism
R44$10,999,321 · 6
R43$392,371 · 1
R41$224,940 · 1
Investigators at Emocha Mobile Health, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Evaluation of a mobile app-based video Directly Observed Therapy (video DOT) intervention for medication adherence in pediatric heart transplant patients$838,636
R44 · FY2023 · HL
Evaluation of a mobile app-based video Directly Observed Therapy (video DOT) intervention for medication adherence in pediatric heart transplant patients$837,410
R44 · FY2024 · HL
Development and Evaluation of Video-Based Directly Observed Therapy for Office-Based Treatment of Opioid Use Disorders with Buprenorphine$828,035
R44 · FY2019 · DA
Development and Evaluation of a Mobile Directly Observed Therapy Smartphone App for Immunosuppressive Adherence in Transplant Patients$744,727
R44 · FY2020 · DK
Development and Evaluation of Video-Based Directly Observed Therapy for Office-Based Treatment of Opioid Use Disorders with Buprenorphine$731,871
R44 · FY2018 · DA
Development and Evaluation of a Mobile Directly Observed Therapy Smartphone App for Immunosuppressive Adherence in Transplant Patients$728,484
R44 · FY2021 · DK
Video observed therapy to enhance flexibility and reduce in-person visits for patients treated with methadone in a multi-site opioid treatment program$659,386
R44 · FY2024 · DA
Video observed therapy to enhance flexibility and reduce in-person visits for patients treated with methadone in a multi-site opioid treatment program$654,494
R44 · FY2023 · DA
Video observed therapy to enhance flexibility and reduce in-person visits for patients treated with methadone in a multi-site opioid treatment program$650,426
R44 · FY2025 · DA
ADHERE (Applying Directly observed therapy to HydroxyurEa to Realize Effectiveness)$649,256
R44 · FY2025 · HL
ADHERE (Applying Directly observed therapy to HydroxyurEa to Realize Effectiveness)$642,844
R44 · FY2023 · HL
Development and Evaluation of Video-Based Directly Observed Therapy for Office-Based Treatment of Opioid Use Disorders with Buprenorphine$623,635
R44 · FY2019 · DA
ADHERE (Applying Directly observed therapy to HydroxyurEa to Realize Effectiveness)$611,906
R44 · FY2024 · HL
Evaluation of National Video Directly Observed Therapy Implementation$499,597
R44 · FY2018 · MD
Evaluation of National Video Directly Observed Therapy Implementation$495,644
R44 · FY2019 · MD
Development and Evaluation of Video-Based Directly Observed Therapy for Office-Based Treatment of Opioid Use Disorders with Buprenorphine$355,967
R44 · FY2019 · DA
Development and Evaluation of Video-Based Directly Observed Therapy for Office-Based Treatment of Opioid Use Disorders with Buprenorphine$224,978
R44 · FY2017 · DA
Feasibility of mHealth technology-enabled service for remote observed therapy of methadone and COVID-19 screening for patients in an opioid treatment program$224,940
R41 · FY2020 · DA
Development and Evaluation of a Mobile Directly Observed Therapy Smartphone App for Immunosuppressive Adherence in Transplant Patients$222,025
R44 · FY2019 · DK
Development and Assessment of Video-Based Directly Observed Therapy for Tuberculosis$198,647
R43 · FY2015 · MD